Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07091318 · ClinicalTrials.gov registry record · Early Phase 1
CBTi for the Treatment of Insomnia in Type 1 Diabetes
A Early Phase 1 study of Insomnia and Diabetes Mellitus, Type 1, sponsored by University of Illinois at Chicago.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT07091318 is a Early Phase 1 study of Insomnia and Diabetes Mellitus, Type 1 that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 15 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07091318, a Early Phase 1 study of Insomnia and Diabetes Mellitus, Type 1, is actively recruiting participants, sponsored by University of Illinois at Chicago.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to learn if treating insomnia with a therapy intervention in people with type 1 diabetes will help to better control sugar levels, sleep, and quality of life. The questions this study aims to answer include: Will this intervention help the insomnia symptoms? Will obtaining better sleep aid in the control of diabetes through measures like sugar levels? Will the intervention help with quality of life factors like mood and fatigue? Researchers will compare participants receiving the therapy intervention for sleep with those in the "healthy living" intervention to see if the outcomes are different based on the treatment. Participants in the therapy intervention group will: * meet virtually with a therapist for 8 sessions via Zoom. Once a week for the first 4 weeks and then every other week for the last 4 sessions. Participants in the healthy living group will: * receive weekly health education emails * receive brief weekly calls from a coach to answer any questions Participants, regardless of intervention, over the 12 week study period will: * monitor their sleep for 2 weeks through a sleep-monitoring watch * share their continuous glucose monitoring data throughout the study * answer questionnaires prior to the intervention, halfway through the intervention and then after the intervention * attend 3 in person office visits
Conditions Studied
Interventions
- BEHAVIORAL Healthy Living
- BEHAVIORAL Sleep quality improvement therapy
Study Locations (1)
Illinois
- University of Illinois Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2025-12-01 |
| Est. Completion | 2027-06-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07091318
The ClinicalTrials.gov registry entry for NCT07091318 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (91% lower). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Insomnia appearing as the primary indexed condition, and to 2 interventions - of which Healthy Living is the first listed.
NCT07091318 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT07091318 about?
NCT07091318 is a clinical study titled "CBTi for the Treatment of Insomnia in Type 1 Diabetes". The goal of this study is to learn if treating insomnia with a therapy intervention in people with type 1 diabetes will help to better control sugar levels, sleep, and quality of life. The questions this study aims to answer include: Will this intervention help the insomnia symptoms? Will obtaining...
What is the current status of trial NCT07091318?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 15 participants. The study started on 2025-12-01. Estimated completion is 2027-06-30.
What conditions does trial NCT07091318 study?
This clinical trial studies the following conditions: Insomnia, Diabetes Mellitus, Type 1.
What interventions are being tested in trial NCT07091318?
The interventions under investigation include: Healthy Living (BEHAVIORAL), Sleep quality improvement therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT07091318?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07091318 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insomnia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia
RECRUITING · Early Phase 1
-
Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in Pregnant Women Exposed to QUVIVIQ®
RECRUITING
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Mindfulness Meditation for Insomnia
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.